LFG
AGIO icon

Larson Financial Group’s Agios Pharmaceuticals AGIO Stock Holding History

Larson Financial Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45K Hold
66
– – ﹤0.01% 3051
2026
Q1 		$2.23K Buy
+66
New +$1.87K ﹤0.01% 2924
2025
Q4 		– Sell
-74
Closed -$2.97K – 3455
2025
Q3 		$2.97K Buy
+74
New +$2.78K ﹤0.01% 2548

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Larson Financial Group's AGIO Position: Q2 2026 in Review

Larson Financial Group held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 66 shares worth $2.45K. The position accounts for ﹤0.01% of the portfolio, ranked #3051.

Larson Financial Group first reported a position in AGIO in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.97K in Q3 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Larson Financial Group held 66 shares of Agios Pharmaceuticals worth $2.45K as of Q2 2026.
  • Larson Financial Group left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3051 holding.
  • Larson Financial Group first reported a position in Agios Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Larson Financial Group's Agios Pharmaceuticals position peaked at $2.97K in Q3 2025.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.